Objective: To describe trends in the prevalence of prescribed attention-deficit hyperactivity disorder (ADHD) medication by Canadian preschoolers and school-age children and to compare these with trends in the prevalence of the ADHD diagnosis between 1994 and 2007.
W ith an estimated worldwide-pooled prevalence of 5.3%, ADHD is the most prevalent mental disorder in children. 1 At the end of the 1990s, stimulants were the most frequent way of dealing with ADHD. 2 Timetrend investigations have revealed a worldwide increase in the prevalence of ADHD diagnosis [3] [4] [5] [6] [7] and prescribed medication, notably methylphenidate, amphetamine salt, and atomoxetine. 4, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Our goal is to describe these time trends within the Canadian context, with a special focus on age-and sex-specific prevalence in a representative sample of nonreferred children. We believe it is important, for the work of clinicians, researchers, and public policy advisers, to shed light on these trends, as medication-and particularly the misuse thereof-has economic and social costs for society. 17 Moreover, these trends may increase our understanding of the medicalization of ADHD.
From 1979 to 1996, a 5.4-fold increase in the prevalence of ADHD diagnosis in children was observed in the United States. 3 This could be partially explained by the changes in diagnostic criteria that have come with every new version of the DSM (DSM-III, 18 DSM-III-R, 19 and DSM-IV 20 ). 21 Further, many studies reported a steep increase in the 1990s; indeed, the prevalence of ADHD diagnosis more than doubled during that period. 4, 5, 7 The prevalence of prescribed stimulants also increased rapidly during the 1990s, 4, 5, 22, 23 aided notably by children with a diagnosis of ADHD being 2 to 3 times more likely to be treated with medication at the end of the 20th century. [3] [4] [5] The availability of new formulas, the increase in offlabel use, the aggressive marketing of pharmaceutical products, and a wider acceptance of this form of treatment by educational authorities and parents alike are some hypotheses that may explain the increase over time in the prevalence of ADHD medications. The rise of the prevalence of ADHD and of prescribed medications continued into the first decade of the 2000s, 6, 7, [9] [10] [11] [12] 24, 25 but less is known about this trend as existing studies often cover too short a time to make indisputable statements about trends for this period.
Although differences in the nature of the sample (insured, clinical, or population-based) and the period of observation could restrict the comparison of trends between studies, the increase in the prevalence of prescribed medications over time was reported to be apparent for all age groups and both sexes. However, there is a special concern regarding preschoolers, as the prevalence of prescribed stimulants for this group drastically increased in the United States. 23, 26 Although not all studies confirm this upward trend, 6, 27 the situation calls for investigation as medication for this age group is prescribed off-label, that is, for an unapproved purpose or population. [28] [29] [30] As few control trials have been conducted on this specific population, the efficacy of medication on preschoolers' ADHD behaviour and the short-and long-term impact on these children's brain and global development are still unknown. 29, [31] [32] [33] Moreover, the controversy around the ADHD diagnosis 34, 35 is particularly lively when it comes to preschoolers, as the line between normal and pathological behaviour may be quite difficult to draw, especially as no specific diagnosis tools exist for this population. 31, 32, 36 Regarding sex-specific prevalence, it is well known that boys have always had a greater prevalence of ADHD and prescribed medications than girls. However, the steepest increase over time in ADHD 5 and in prescribed medications was observed in the latter group. 9 
Clinical Implications
• Girls diagnosed with ADHD are less likely to have a concomitant prescription of ADHD medication.
• Off-label use of ADHD medication is most common among preschoolers.
• School-age children have a greater prevalence than preschoolers, suggesting the importance that assessments account for school environment.
Limitations
• Prevalence may be underestimated here, as information about ADHD diagnosis and prescribed medications was provided by parents.
• The National Longitudinal Survey on Children and Youth does not address the quality of medical care or the appropriateness of stimulant prescriptions.
• The length of trends for ADHD diagnosis is limited to the 2000s, as this information was not collected in 1994-1995.
chez les filles, mais les filles montrent la croissance la plus abrupte avec le temps, jusqu'à 2,1 fois. or the acknowledgement that sex differences may result from referral bias. 38, 39 The prevalence of mental health problems has increased throughout the 20th century. This is due in part to societal changes, notably individualism, competitiveness, and technological, medical, and pharmaceutical innovations. Thus observing time trends is of importance, particularly as improvements to either medications or diagnoses were (and will be) implemented in the 2000s. The introduction of new ADHD medications in Canada in 2003, [40] [41] [42] new long-acting and more effective formulas, 43 or the release of the DSM-5 in 2013 44 are examples of changes that may have an impact on the prevalence of the phenomena under study.
By using a broader timeframe than previous studies, we seek to describe age-and sex-specific trends in the prevalence of prescribed ADHD medications and ADHD diagnosis in a population-based sample of young Canadians for 1994-2007. We also compare these 2 time trends and report the strength of their association by estimating the proportion of children with ADHD taking medications and, inversely, that of children taking medications also diagnosed with ADHD. Based on previous research, we expect the increase of prevalence to be apparent for all age groups, though more pronounced for girls, and that time trends for prescribed medications and ADHD diagnosis will show similar patterns. Besides informing psychiatrists and clinicians about the social epidemiology of ADHD and ADHD medication in Canada, our study will allow them to reflect on their prescription patterns, especially off-label ones, and to compare them with those of their colleagues.
Methods
Subjects participated in the NLSCY, a Canadian prospective survey made up of 8 data collection cycles occurring biennially between 1994-1995 and 2008-2009. The NLSCY was designed to gather data on child life experiences and development. Participating households were selected through the Statistics Canada's Labour Force Survey using a stratified multistage probability sample. Children from Canadian territories, remote areas, First Nation reserves, and institutional facilities, as well as children with an immediate family member in the army, were excluded. 45 Information on the NLSCY is available on the Statistics Canada website. 46 Besides were selected for the analyses. The remaining cycles were dropped either because ADHD information was not collected before 2000-2001 or because some age groups, children aged 6 to 11 years and children aged 9 years or older, were not surveyed at cycles 5 and 6, and cycle 8, respectively.
Children aged 2 years or younger were excluded owing to lack of information on ADHD diagnosis. Children aged 10 years or older were also excluded from the NLSCY cross-sectional samples by Statistic Canada, as they were unrepresentative of Canadian children after 2001. 46 Children were classified into 2 groups, created according to the age of entry in elementary school in Canada. Preschoolers included children aged 3 to 5 years, while children aged 6 to 9 years were part of the school-age group. This classification also respects the Canadian Pharmacists Association's recommendation not to prescribe ADHD medication to children aged 5 years and younger. 28 Information on prescribed Ritalin or other similar medication 47 regularly used by children was reported at each cycle of data collection by the person most knowledgeable about the child (the biological parent in 98% of the cases, usually the mother). Ritalin, the commercial name of a stimulant containing methylphenidate as its active ingredient, was (and still is) the medication most prescribed for ADHD in Canada. 48 Since 2003, other medications used to treat ADHD were accepted by Health Canada: atomoxetine (Strattera), amphetamine salt (Dexedrine; Adderall XR, which was suspended in 2005 for a short period by Health Canada 41, 49, 50 ), 40 and a recent amphetamine (Vyvanse). 42 The presence of a child's psychiatric diagnosis of ADHD was also reported by the person most knowledgeable about the child, but only as of 2000-2001.
The nonresponse rate was low (less than 2.5%). Information on medication intake was missing for 2.0% of the respondents at cycle 1, 2.3% at cycle 4, and 0.1% at cycle 7; while information on ADHD lacked for 2.5% of the respondents at cycle 4 and 0.1% at cycle 7. We used the listwise deletion technique and sampling weights, which provide unbiased estimates completely at random when data are missing. 51 The prevalence of ADHD diagnosis and medication intake was estimated by sex and age group. Prevalence is shown in percentages. The numerator corresponds to the number of children with the condition within the subgroup, while the denominator corresponds to the total number of children in that subgroup. Logistic regressions were used to identify significant differences in prevalence between cycles, sex, and age group. All analyses were done using the recommended cross-sectional and bootstrap weights, thus ensuring the reliability of the estimates and confidence intervals. 45
Results

Time Trends: From 1994-1995 to 2006-2007
As shown in Table 1 , the prevalence of prescribed ADHD medications for Canadian children aged 3 to 9 years has significantly increased by 1.6-fold between 1994 and 2007 (from 1.3% to 2.1%). However, it is essentially attributable to the 1.4-fold increase that happened during the first decade of the 2000s (from 1.4% in 2000 to 2.1% in 2007). Regarding ADHD diagnosis, Table 2 shows a similar 1.5-fold increase in the prevalence observed between 2000 and 2007 (from 1.7% to 2.6%).
The association between prescribed medications and ADHD diagnosis strengthened in the 2000s. In 2000, 43.4% of the children aged 3 to 9 years with ADHD were taking medications, which significantly increased to 59.3% in 2007 (Table 3) . Moreover, medication users were 53.1% to report a diagnosis of ADHD in 2000, while 76.3% reported this diagnosis in 2007 (Table 4 ), leading to a decrease in the off-label use of ADHD medications.
Time Trends by Sex
Trends in the prevalence of prescribed medications reveal different patterns of increase between 1994 and 2007 according to sex (Table 1) . Although boys' prevalence of prescribed medications and ADHD diagnosis was the highest at every period, the increase over time was steepest for girls, thus slightly narrowing the gender gap in 2007.
Boys' prevalence followed the general time trend by increasing 1.7-fold during the first decade of the 2000s (from 1.8% in 2000 to 3.1% in 2007). The increase of prescribed medication occurred earlier for girls, as the significant 2-fold increase occurred in the last decade of the 1990s (from 0.5% in 1994 to 1.0% in 2001) and then stabilized in the 2000s. Regarding ADHD diagnosis, the prevalence increased between 2000 and 2007 for both sexes. Table 2 shows a 1.4-fold increase for boys (from 2.6% to 3.7%) and a 1.7-fold increase for girls (from 0.9% to 1.5%).
A comparison of the trends in prevalence of prescribed medications with that of ADHD diagnosis for boys revealed an equivalent increase over time: a 1.7-fold and a 1.4-fold growth between 2000 and 2007, respectively. However, a discrepancy was found for girls, for whom the prevalence of ADHD diagnosis increased 1.7-fold between 2000 and 2007, though the prevalence of prescribed medications stayed stable over that period.
Trends in the association between prescribed medications and ADHD diagnosis are sex-dependent. The proportion of medication users among girls with a diagnosis of ADHD was stable between 2000 and 2007, but increased for boys over that period (from 40.6% to 63.3%) ( Table 3 ). Further, the proportion of children with a diagnosis of ADHD among medication users increased from 2000 to 2007: a 1.3-fold increase for boys (from 56.7% to 75.7%) and a 1.7-fold increase for girls (from 46.1% to 78.4%) ( Table 4 ).
Time Trends by Age Group
Compared with school-age children, preschoolers had a significantly lower prevalence of medication intake and of ADHD diagnosis at every period. As shown in Table 1 , preschoolers' prevalence of prescribed medications was stable between 1994 and 2007, given that the slight decrease (from 0.5% to 0.3%) is not statistically significant. Prevalence for school-age children increased over that period (from 1.9% to 3.3%), but this is essentially attributable to the 1.6-fold rise that occurred in the 2000s (from 2.1% to 3.3%).
Similar trends are found for the prevalence of ADHD diagnosis ( Table 2 ). Preschoolers' prevalence remained statistically stable (from 1.1% to 0.5%) between 2000 and 2007, while that of school-age children increased 1.9-fold during that period (from 2.2% to 4.1%). Therefore, the association between prescribed medications and ADHD diagnosis strengthened in the 2000s, but only for school-age children. Between 2000 and 2007, the proportion of medication users among children with a diagnosis of ADHD was stable for preschoolers, but increased for school-age children (from 50.0% to 62.7%) ( Table 3) . Similar trends were observed regarding the proportion of children with a diagnosis of ADHD among medication users from 2000 to 2007: the proportion of preschoolers remained stable, while that of schoolage children increased 1.5-fold (from 52.7% to 78.0%) ( Table 4 ).
Discussion
Our study describes trends in the prevalence of prescribed ADHD medications and compares them with that of ADHD diagnosis among Canadian preschoolers and school-age children between 1994 and 2007. Our results reveal that:
1. The upward trend in the prevalence of prescribed medications and ADHD diagnosis currently observed in contemporary societies is also taking place in Canada. The rise occurred essentially during the first decade of the 2000s, except for girls, for whom it happened in the late 1990s;
2. Preschoolers' prevalence of prescribed medications and ADHD diagnosis stayed stable between 1994 and 2007, while that of school-age children increased;
3. Boys' prevalence of prescribed medications and ADHD diagnosis was higher than girls', but girls show the steepest increase over time;
4. Time trends in the prevalence of prescribed medications and ADHD diagnosis show similar patterns, except for girls; and 5. We observed a greater number of medication users among children with ADHD in 2007, and a decrease in off-label use of prescribed medications among schoolage children for that period.
Upward Trend in the 2000s
Despite the observed increase over time, the estimated prevalence of prescribed ADHD medications and ADHD diagnosis in Canada was generally low (less than 3%), with slightly higher prevalence for boys (less than 4%) and school-age children (less than 5%). The greatest increase of prevalence of prescribed medications occurred between 2000 and 2007, which is concordant with results showing greater overall use of and expenditure on ADHD medication between 2000 and 2003 than between 1993 and 2000. 15 The availability in Canada of new long-acting ADHD medications 43 combined with the publication (and update) of ADHD guidelines in the 2000s 40, 52, 53 have undoubtedly increased physicians' awareness and recognition of ADHD symptoms, as well as bolstered their trust in the pharmaceutical treatment of this disorder.
The increase we observed in Canada takes place in a broader context and may result from the combination of many factors. The 20th century was characterized notably by a change in the way psychiatry conceptualized mental health problems. 34, 54, 55 Once described by psychoanalytic theories, they are now increasingly seen through a neurobiological lens. This may have resulted in an 
Time Trends of Age-Specific Prevalence
The increase observed in the prevalence of prescribed medications 6, [9] [10] [11] 16, 23, 24 and ADHD diagnosis 3-7 for schoolage children was expected, even within the Canadian context. 8, 14, 25, 37 This could reflect previous findings that school teachers and professionals are agents of medicalization [56] [57] [58] [59] facilitating the identification of children with behavioural problems and referring them to medical authorities. The ADHD diagnosis, as well as medication intake, are effectively more common during the first years of elementary school, 4, 5, 23 notably because the routine, discipline, organization, and resources of school make it easier to identify children who do not conform to social norms. 56 In many cases, school can be the first environment conducive to identifying a child's ADHD 58, 60 and may play an important part in the treatment of ADHD, either by delivering behavioural intervention in school 61 or allowing children to take their medication during school hours. 59 Diagnosis, but especially medications, were identified as new ways of social control in to the classroom, thus replacing more traditional forms of disciplinary measures (physical punishment, suspension, or expulsion). 58 As we expected an increase in the prevalence of ADHD medications to be found in all age groups, 14 the stable prevalence we found for preschoolers between 1994 and 2007 comes as a surprise. Our results nevertheless confirm 2 studies, 6, 27 which both observed stability in the prevalence of prescribed stimulants for preschoolers at the beginning of the 2000s. This may be due to the attenuation of the steep increase that was observed at the beginning of the 1990s 23, 27 or may simply indicate that Canadian physicians are more conservative when it comes to prescribing medication to preschoolers. In either case, future monitoring of the trends in the prevalence of medication intake by preschoolers is needed, as the efficacy of medication is rarely tested on this population. 31, 62 
Time Trends for Girls
Interestingly, girls' prevalence of prescribed medications and ADHD diagnosis increased more rapidly than boys', thus contributing to attenuating the differences between the sexes. Between 1994 and 2001, the male-to-female ratio decreased from 4:1 to 2:1 for prescribed ADHD medication and, between 2000 and 2007, from 3:1 to 2:1 for ADHD diagnosis. This narrowing of the sex gap was observed elsewhere for a similar time period. In a comparable Canadian study, 37 the male-to-female ratio for prescribed stimulants went from 4:1 to 2:1 and, in an American office-based survey, 16 from 5:1 to 4:1. Possibly being misdiagnosed or underdiagnosed, girls have been identified as underrepresented in former ADHD research samples. 38, 63 This increase in pharmaceutical treatment and ADHD diagnosis for girls may reflect the greater attention they are now receiving. 5 Unexpectedly, girls' prevalence of prescribed medications essentially increased at the end of the 1990s to stabilize during the first decade of the 2000s, while the prevalence of ADHD almost doubled during that period. This is puzzling, as we would have expected the prevalence of prescribed medications to increase steadily over the years. Nevertheless, the increase in the prevalence of ADHD between 2000 and 2007 could reflect the release of the DSM-IV and DSM-IV-R, 20, 64 which give back to symptoms of inattention, common in girls, 38 the place they held before the DSM-III-R. 19 The stability of prescribed stimulants for girls over the same period may thus corroborate results revealing that American girls are less likely to receive treatment after being diagnosed with ADHD. 2 This would also be congruent with our results showing that the proportion of medication users among girls with ADHD stayed stable in the 2000s, while that of boys increased.
Association Between Prescribed ADHD Medication and ADHD Diagnosis
Our results confirm that the association between pharmaceutical treatments and ADHD diagnosis has strengthened over the years. [3] [4] [5] 7 Stimulant medications, notably indicated to treat narcolepsy, behaviour problems, or learning difficulties, 65 seem to have become the most popular treatment for ADHD as the proportion of medication users among children with ADHD has reached nearly 60% in 2007. This could reflect the greater willingness of physicians to prescribe medication to children and youth, 16 the availability of more effective medication 43 or the lack of resources for other treatments. 66 Conversely, off-label use of medication declined in the 2000s, as children with a prescription of ADHD medications and a concomitant diagnosis of ADHD increased in 2007 (76.3%), which is consequent with the previous result. However, this trend was not observed for preschoolers, for whom off-label prescription of medications slightly increased over the same period (from 44.3% to 56.2%). This may suggest that ADHD medication intake by preschoolers is related to other diagnoses, for instance, conduct disorder or oppositional defiant disorder. 65 Moreover, it may be a good indication of the extent of the Canadian trend in offlabel prescriptions, which is lower than in the United States where 50% to 75% of pediatric medical practices result in off-label prescription. 62
Limitations and Future Research
The NLSCY is not a database of drug claims or a registry of ADHD patients. Therefore, it does not address the quality of medical care, the appropriateness of prescriptions, and is not reflective of the total Canadian prescribing and diagnosing patterns. It also does not give information about the name of the medication (besides indicating it is an ADHD medication), the date of initiation, its dose, and the frequency of and reason for intake. Consequently, though they do converge with results from previous studies, our results may underestimate the prevalence of medication use and ADHD diagnosis. Finally, some methodological limits of the NLSCY have restricted the length of the trends for ADHD diagnosis, the age group included, and the presence of province-specific prevalence by sex and age group. 25 Future research should continue identifying time trends in the prevalence of medication use and ADHD, especially for girls and preschoolers. Estimation of sex-and age-specific prevalence by province is also required, as health care and drug insurance programs rely on provincial regulations. Further investigations will be essential to gain a better understanding of the nature of the relation between ADHD diagnosis and medication use and the direction such a link may be taking: Does the trend in the prevalence of ADHD diagnosis explain trends in medication use? Or might it be the opposite? Both hypotheses are plausible 57 and determining the factors associated with these trends may be one of the only ways to identify whether children are overmedicalized.
Conclusions
In Canada, the prevalence of prescribed ADHD medications and of ADHD diagnosis was increasing at the same pace during the first decade of the 2000s. While preschoolers' prevalence stayed stable during this period, girls and school-age children experienced the greatest increase over time. Pharmaceutical treatments of ADHD have become more popular over the years, and off-label use of stimulants is declining for school-age children.
